Bond Laboratories' SirenLabs™ Brand is a Hit


Bond Laboratories' SirenLabs™ Brand is a Hit

SirenLabsGenerates Tremendous Initial Feedback

OMAHA, Neb.--(BUSINESS WIRE)-- Bond Laboratories, Inc. (OTCBB:BNLB) ("Bond Labs"), an international provider of innovative and proprietary nutritional supplements for health conscious consumers, is pleased to report that SirenLabs™ (, the Company's dynamic new line of high-quality nutritional supplements, has received tremendous initial feedback. "The launch of the SirenLabs brand of nutritional supplements has been a huge success for us," stated Bond Labs' Chief Executive Officer, John Wilson. "In just its first month, SirenLabs products are already available in 79% of our top 100 customer's retail locations."

"Building on the tremendous success of our NDS™ brand, SirenLabs™ enables the Company to enhance its position with GNC by offering a second full line of high quality products," continued Mr. Wilson. "Adding brand and product differentiation allows us to offer a broader suite of effective solutions to our loyal customers, at the same time increasing shelf space and enhancing product visibility. This equates to increased revenue growth while also providing opportunities to exploit economies of scale and cost saving synergies. I am truly excited about the contributions SirenLabs™ will provide to the Company over the remainder of the fiscal year," concluded Mr. Wilson.

About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through NDS Nutrition Products ("NDS"), a wholly owned operating division. NDS sells over 50 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health exclusively to GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit

Forward-Looking Statement
Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Company's pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company's filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

For Bond Laboratories:
Surety Financial Group, LLC
Bruce Weinstein, 410-833-0078

KEYWORDS: United States North America California Nebraska


The article Bond Laboratories' SirenLabs™ Brand is a Hit originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published